Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings are published today in Nature Communications.
For years, Dr. Andréa LeBlanc, Senior Investigator at the LDI and Professor of Neurology and Neurosurgery at McGill University, has strived to identify early neurodegenerative events responsible for age-related memory loss. Her team discovered that the Caspase-6 enzyme is highly activated in Alzheimer disease brain lesions and associated with loss of memory. She, therefore, pursued the hypothesis that stopping Caspase-6 might provide relief from memory loss and stop progressive dementia. Since there are no specific Caspase-6 inhibitors, the LeBlanc team moved upstream, ultimately discovering that Caspase-1 was responsible for activating Caspase-6.
“This was a significant revelation because Caspase-1 inhibitors had been developed for treating inflammatory diseases,” explains Dr. LeBlanc. “Thus, we decided to test the effects of a particular Caspase-1 inhibitor, called VX-765, against memory loss and brain pathologies in a mouse model of Alzheimer disease.”
The work, first authored by Dr. Joseph Flores, a research associate in the LeBlanc lab, showed that VX-765 has an unprecedented beneficial effect in Alzheimer mice. The drug rapidly reverses memory loss, eliminates inflammation, and stops Alzheimer’s prototypical amyloid peptide accumulation in the mice brains. In addition to being safe for humans at relatively high doses for extended periods of time, it is capable of reaching the brain, a significant challenge in the development of drugs against disorders of the brain.
While Dr. LeBlanc cautions that there is a considerable bridge to cross between the mouse brain and that of a human, she believes that since her work has first identified the Caspase-1/Caspase-6 neurodegenerative pathway in human neurons and in human Alzheimer brains, there is a chance that this drug will work just as well in humans as it did in mice. Nevertheless, a clinical trial is needed to determine whether the drug will be beneficial against Alzheimer disease in humans.
Presently, there are no efficient treatments to significantly treat Alzheimer disease, the major affliction in a group of dementias that affect 47.5 million individuals worldwide.
The Latest on: Alzheimer’s
[google_news title=”” keyword=”Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s
- New breakthroughs in Alzheimer's treatment, but more research is neededon February 26, 2024 at 4:05 am
TAMPA, Fla. — New breakthroughs in the treatment of Alzheimer's Disease, but doctors say more research is needed, particularly in the African American community. Conveniently, a study being done right ...
- Alzheimer's: Five Wishes advance directive also covers comfort, spiritualityon February 26, 2024 at 3:00 am
What is the Five Wishes document? Created by Jim Towey and the nonprofit organization he founded, Aging with Dignity, Five Wishes is an advance directive that was introduced in 1996 as a Florida-only ...
- Dementia Specialist Turns Patient - His Strategy to Slow Down Alzheimer'son February 26, 2024 at 12:30 am
He adjusts his lifestyle and relies on medications to slow down the progression.First Alzheimer's Symptom at Age 55"Looking back, my first Alzheimer's symptom appeared in 2006. I was 55 years old when ...
- ‘American Fiction,’ Alzheimer’s, and mid-century momson February 26, 2024 at 12:00 am
My mother was in bed, resting, and I was sprawled alongside her.“Look at her hair,” she said, in a carefree tone I wasn’t used to hearing. “Isn’t it beautiful?”I rolled over to see who had entered the ...
- Kansas City man with Alzheimer’s found safe after reported missing from his home Sundayon February 25, 2024 at 4:19 pm
According to police, Maurice E. Robinson walked away from his residence near Bannister Road and Belmont Avenue around 2:30 p.m. Sunday. Philip DiMartino, a spokesperson for KCPD, said it’s not clear ...
- AI Predicts Alzheimer's Disease Risk Seven Years in Advanceon February 25, 2024 at 8:09 am
Researchers at the University of California, San Francisco (UCSF) recently developed an AI algorithm that can identify patients at risk for developing Alzheimer’s disease up to seven years in advance, ...
- Researchers find association between air pollution and Alzheimer’s diseaseon February 25, 2024 at 4:30 am
The study contributes to already existing evidence that breathing pollution may lead to “plaques” or deposits in the brain — a hallmark of Alzheimer’s disease.
- AI can predict Alzheimer’s disease up to seven years before symptoms appear, study findson February 24, 2024 at 12:00 pm
Scientists have developed a machine learning model that predicts Alzheimer's onset up to seven years early, identifying high cholesterol and osteoporosis as key predictors, especially in women.
- New research shows Alzheimer's ravages the brain long before symptoms appearon February 24, 2024 at 10:18 am
WASHINGTON — Alzheimer's quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes — a potential window to one day ...
via Bing News